Naiki, T.
140  results:
Search for persons X
?
 
?
3

Pelvic anatomical features after Retzius-sparing robotic-as..:

Hamamoto, S. ; Ota, Y. ; Naiki, T....
European Urology Supplements.  18 (2019)  1 - p. e791-e792 , 2019
 
?
4

Novel selective lysine specific demethylase 1 inhibitors ef..:

Etani, T. ; Naiki, T. ; Nagai, T....
European Urology Supplements.  18 (2019)  1 - p. e1338-e1339 , 2019
 
?
5

The impact of a past medical history of upper urinary tract..:

Iida, K. ; Naiki, T. ; Nagai, T....
European Urology Supplements.  18 (2019)  1 - p. e936-e937 , 2019
 
?
6

Luteolin regulates AR-V7 expression via miRNA recruitment i..:

Naiki, T. ; Naiki-Ito, A. ; Etani, T....
European Urology Supplements.  18 (2019)  1 - p. e332-e333 , 2019
 
?
7

919 The role of M1/M2 macrophages for CaOx stone and Randal..:

Taguchi, K. ; Okada, A. ; Hamamoto, S....
European Urology Supplements.  15 (2016)  3 - p. e919 , 2016
 
?
8

1151 Gemcitabine plus paclitaxel as third-line chemotherapy..:

lida, K. ; Nagai, T. ; Etani, T....
European Urology Supplements.  15 (2016)  3 - p. e1151 , 2016
 
?
 
?
10

Clinical trial: extended treatment duration of peginterfero..:

NAGAKI, M. ; SHIMIZU, M. ; SUGIHARA, J. I....
Alimentary Pharmacology & Therapeutics.  30 (2009)  4 - p. 343-351 , 2009
 
?
11

Prospective study on early virologic response to treatment ..:

NAGAKI, M ; IMOSE, M ; NAIKI, T...
Hepatology Research.  33 (2005)  4 - p. 285-291 , 2005
 
1-15